Reviewed,
UniProtKB/Swiss-Prot P35221 (CTNA1_HUMAN)
Last modified
November 3, 2009.
Version 104.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Catenin alpha-1 Alternative name(s): Cadherin-associated protein Alpha E-catenin NY-REN-13 antigen | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Complete proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 906 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Associates with the cytoplasmic domain of a variety of cadherins. The association of catenins to cadherins produces a complex which is linked to the actin filament network, and which seems to be of primary importance for cadherins cell-adhesion properties. May play a crucial role in cell differentiation. |
| Subunit structure | Binds MLLT4 and F-actin By similarity. Interacts directly with PSEN1 and CTNNB1 to form part of the PSEN1/cadherin/catenin adhesion complex. Interacts with ARHGAP21 and with JUB. |
| Subcellular location | Cytoplasm › cytoskeleton. Cell junction › adherens junction. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cell junction. Note: Found at cell-cell boundaries and probably at cell-matrix boundaries. |
| Tissue specificity | Expressed ubiquitously in normal tissues. |
| Post-translational modification | Sumoylated. Ref.13 |
| Involvement in disease | Abnormalities of alpha-catenin are involved in the process of cancer invasion and metastasis. |
| Sequence similarities | Belongs to the vinculin/alpha-catenin family. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P35221-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P35221-2) The sequence of this isoform differs from the canonical sequence as follows: 811-811: G → GNCDTCGALQGLKGWPPPLCLATHW |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.7 | ||||||||||||||||||||||||||||||||
| Chain | 2 – 906 | 905 | Catenin alpha-1 | PRO_0000064261 | |||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||
| Modified residue | 2 | 1 | N-acetylthreonine Ref.7 | ||||||||||||||||||||||||||||||||
| Modified residue | 177 | 1 | Phosphotyrosine Ref.17 | ||||||||||||||||||||||||||||||||
| Modified residue | 186 | 1 | N6-acetyllysine Ref.23 | ||||||||||||||||||||||||||||||||
| Modified residue | 619 | 1 | Phosphotyrosine Ref.17 | ||||||||||||||||||||||||||||||||
| Modified residue | 641 | 1 | Phosphoserine Ref.12 Ref.15 Ref.16 Ref.18 Ref.19 Ref.20 Ref.21 | ||||||||||||||||||||||||||||||||
| Modified residue | 645 | 1 | Phosphothreonine Ref.21 | ||||||||||||||||||||||||||||||||
| Modified residue | 652 | 1 | Phosphoserine Ref.18 Ref.20 | ||||||||||||||||||||||||||||||||
| Modified residue | 654 | 1 | Phosphothreonine By similarity | ||||||||||||||||||||||||||||||||
| Modified residue | 655 | 1 | Phosphoserine Ref.20 | ||||||||||||||||||||||||||||||||
| Modified residue | 658 | 1 | Phosphothreonine Ref.18 Ref.20 | ||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||
| Alternative sequence | 811 | 1 | G → GNCDTCGALQGLKGWPPPLC LATHW in isoform 2. | VSP_017494 | |||||||||||||||||||||||||||||||
| Natural variant | 179 | 1 | A → V | VAR_022303 | |||||||||||||||||||||||||||||||
| Natural variant | 219 | 1 | P → S: dbSNP rs28363406. Ref.5 | VAR_022304 | |||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 92 | 1 | A → V in AAA86430. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 92 | 1 | A → V in AAA18949. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 129 | 1 | R → P in AAA18949. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 175 | 1 | I → N in AAA86430. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 175 | 1 | I → N in AAA18949. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 216 | 1 | K → S in AAA86430. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 216 | 1 | K → S in AAA18949. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 342 | 1 | Q → K in BAA03530. Ref.1 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 344 – 348 | 5 | LQDLL → CRTCV in AAA86430. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 460 | 1 | L → G in AAA86430. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 460 | 1 | L → G in AAA18949. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 469 | 1 | L → TW in AAA86430. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 469 | 1 | L → TW in AAA18949. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 473 | 1 | A → P in AAA86430. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 473 | 1 | A → P in AAA18949. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 653 | 1 | R → E in AAA86430. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 653 | 1 | R → E in AAA18949. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 685 | 1 | A → R in AAA86430. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 685 | 1 | A → R in AAA18949. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 764 | 1 | A → R in AAA86430. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 764 | 1 | A → R in AAA18949. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 789 | 1 | Q → H in BAA03530. Ref.1 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 859 | 1 | W → M in AAA86430. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 859 | 1 | W → M in AAA18949. Ref.3 | ||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||
| Helix | 378 – 386 | 9 | |||||||||||||||||||||||||||||||||
| Helix | 387 – 389 | 3 | |||||||||||||||||||||||||||||||||
| Turn | 393 – 395 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 398 – 409 | 12 | |||||||||||||||||||||||||||||||||
| Helix | 413 – 438 | 26 | |||||||||||||||||||||||||||||||||
| Helix | 444 – 473 | 30 | |||||||||||||||||||||||||||||||||
| Helix | 478 – 506 | 29 | |||||||||||||||||||||||||||||||||
| Helix | 509 – 531 | 23 | |||||||||||||||||||||||||||||||||
| Helix | 535 – 559 | 25 | |||||||||||||||||||||||||||||||||
| Turn | 560 – 562 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 567 – 581 | 15 | |||||||||||||||||||||||||||||||||
| Helix | 583 – 598 | 16 | |||||||||||||||||||||||||||||||||
| Beta strand | 600 – 602 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 608 – 630 | 23 | |||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Structure, expression and chromosome assignment of the human catenin (cadherin-associated protein) alpha 1 gene (CTNNA1)." Furukawa Y., Nakatsuru S., Nagafuchi A., Tsukita S., Muto T., Nakamura Y., Horii A. Cytogenet. Cell Genet. 65:74-78(1994) [PubMed: 8404069] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Brain. |
| [2] | "Cloning of the human alpha-catenin cDNA and its aberrant mRNA in a human cancer cell line." Oda T., Kanai Y., Shimoyama Y., Nagafuchi A., Tsukita S., Hirohashi S. Biochem. Biophys. Res. Commun. 193:897-904(1993) [PubMed: 8323564] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Colon and Lung. |
| [3] | "Molecular cloning reveals alternative splice forms of human alpha(E)-catenin." Rimm D.L., Kebriaei P., Morrow J.S. Biochem. Biophys. Res. Commun. 203:1691-1699(1994) [PubMed: 7945318] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2). Tissue: Colon. |
| [4] | "Genomic organization of the human alphaE-catenin gene (CTNNA1)." Nollet F.H., Vanpoucke G.G., van Roy F.M. Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [5] | NIEHS SNPs program Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS VAL-179 AND SER-219. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Lung. |
| [7] | Bienvenut W.V., Zebisch A., Kolch W. Submitted (DEC-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 2-12; 166-178 AND 617-623, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT THR-2, MASS SPECTROMETRY. Tissue: Colon carcinoma. |
| [8] | "Assignment of the human alpha-catenin gene (CTNNA1) to chromosome 5q21-q22." McPherson J.D., Morton R.A., Ewing C.M., Wasmuth J.J., Overhauser J., Nagafuchi A., Tsukita S., Isaacs W.B. Genomics 19:188-190(1994) [PubMed: 8188230] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 159-250. Tissue: Prostate. |
| [9] | "Antigens recognized by autologous antibody in patients with renal-cell carcinoma." Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H., Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T., Old L.J. Int. J. Cancer 83:456-464(1999) [PubMed: 10508479] [Abstract] Cited for: IDENTIFICATION AS A RENAL CANCER ANTIGEN. Tissue: Renal cell carcinoma. |
| [10] | "Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts." Georgakopoulos A., Marambaud P., Efthimiopoulos S., Shioi J., Cui W., Li H.-C., Schutte M., Gordon R., Holstein G.R., Martinelli G., Mehta P., Friedrich V.L. Jr., Robakis N.K. Mol. Cell 4:893-902(1999) [PubMed: 10635315] [Abstract] Cited for: COMPONENT OF THE PSEN1/E-CADHERIN/CATENIN ADHESION COMPLEX WITH PSEN1; CDH1; CTNNA1 AND CTNNB1/CTNND1. |
| [11] | "The LIM protein Ajuba is recruited to cadherin-dependent cell junctions through an association with alpha-catenin." Marie H., Pratt S.J., Betson M., Epple H., Kittler J.T., Meek L., Moss S.J., Troyanovsky S., Attwell D., Longmore G.D., Braga V.M. J. Biol. Chem. 278:1220-1228(2003) [PubMed: 12417594] [Abstract] Cited for: INTERACTION WITH JUB. |
| [12] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641, MASS SPECTROMETRY. Tissue: Epithelium. |
| [13] | "Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates." Gocke C.B., Yu H., Kang J. J. Biol. Chem. 280:5004-5012(2005) [PubMed: 15561718] [Abstract] Cited for: SUMOYLATION. |
| [14] | "ARHGAP10 is necessary for alpha-catenin recruitment at adherens junctions and for Listeria invasion." Sousa S., Cabanes D., Archambaud C., Colland F., Lemichez E., Popoff M., Boisson-Dupuis S., Gouin E., Lecuit M., Legrain P., Cossart P. Nat. Cell Biol. 7:954-960(2005) [PubMed: 16184169] [Abstract] Cited for: INTERACTION WITH ARHGAP21. |
| [15] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641, MASS SPECTROMETRY. Tissue: Epithelium. |
| [16] | "Phosphoproteomic analysis of the human pituitary." Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F. Pituitary 9:109-120(2006) [PubMed: 16807684] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641, MASS SPECTROMETRY. Tissue: Pituitary. |
| [17] | "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer." Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M. Comb M.J.Cell 131:1190-1203(2007) [PubMed: 18083107] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-177 AND TYR-619, MASS SPECTROMETRY. |
| [18] | "Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line." Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S. Electrophoresis 28:2027-2034(2007) [PubMed: 17487921] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641; SER-652 AND THR-658, MASS SPECTROMETRY. |
| [19] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641, MASS SPECTROMETRY. |
| [20] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641; SER-652; SER-655 AND THR-658, MASS SPECTROMETRY. |
| [21] | "Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography." Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D., Zou H., Gu J. Proteomics 8:1346-1361(2008) [PubMed: 18318008] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641 AND THR-645, MASS SPECTROMETRY. Tissue: Liver. |
| [22] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [23] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed: 19608861] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-186, MASS SPECTROMETRY. |
| [24] | "Crystal structure of the M-fragment of alpha-catenin: implications for modulation of cell adhesion." Yang J., Dokurno P., Tonks N.K., Barford D. EMBO J. 20:3645-3656(2001) [PubMed: 11447106] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 377-632, PARTIAL PROTEIN SEQUENCE, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D14705 mRNA. Translation: BAA03530.1. D13866 mRNA. Translation: BAA02979.1. L23805 mRNA. Translation: AAA86430.1. U03100 mRNA. Translation: AAA18949.1. AF102803 AF102802 Genomic DNA. Translation: AAC99459.1. AY884207 Genomic DNA. Translation: AAW56940.1. BC000385 mRNA. Translation: AAH00385.1. L22080 mRNA. Translation: AAA35502.1. | |||||||||||||
| IPI | IPI00215948. IPI00473136. | ||||||||||||
| PIR | JC2542. JN0607. | ||||||||||||
| RefSeq | NP_001894.2. | ||||||||||||
| UniGene | Hs.534797 | ||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| SMR | P35221. Positions 57-261. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP:515N. | ||||||||||||
| STRING | P35221. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P35221. | ||||||||||||
Proteomic databases | |||||||||||||
| PeptideAtlas | P35221. | ||||||||||||
| PRIDE | P35221. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000302763; ENSP00000304669; ENSG00000044115; Homo sapiens. [Genome view] ENST00000355078; ENSP00000347190; ENSG00000044115; Homo sapiens. [Genome view] | ||||||||||||
| GeneID | 1495. | ||||||||||||
| KEGG | hsa:1495. | ||||||||||||
| UCSC | uc003ldh.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 1495. | ||||||||||||
| GeneCards | GC05P138117. | ||||||||||||
| H-InvDB | HIX0005216. | ||||||||||||
| HGNC | HGNC:2509. CTNNA1. | ||||||||||||
| HPA | CAB021089. | ||||||||||||
| MIM | 116805. gene. | ||||||||||||
| PharmGKB | PA27008. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOVERGEN | P35221. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Pathway_Interaction_DB | arf6_traffickingpathway. Arf6 trafficking events. | ||||||||||||
| Reactome | REACT_19331. Cell-cell adhesion systems. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P35221. | ||||||||||||
| Bgee | P35221. | ||||||||||||
| CleanEx | HS_CTNNA1. | ||||||||||||
| Genevestigator | P35221. | ||||||||||||
| GermOnline | ENSG00000044115. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR001033. Alpha_catenin. IPR006077. Vinculin/catenin. IPR000633. Vinculin_CS. [Graphical view] | ||||||||||||
| Pfam | PF01044. Vinculin. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR00805. ALPHACATENIN. | ||||||||||||
| PROSITE | PS00663. VINCULIN_1. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| NextBio | 6145. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | CTNA1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P35221 Secondary accession number(s): Q12795 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


